A Study of RVT-1401 in Myasthenia Gravis (MG) Patients

Clinical trial NCT03863080 · COMPLETED

Trial details

NCT number: NCT03863080
Sponsor: Immunovant Sciences GmbH
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myasthenia Gravis

Start date: 2019-05-21
Primary completion: 2020-10-07
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.